Anaptysbio (ANAB) Long-Term Investments (2017 - 2025)
Anaptysbio's Long-Term Investments came in at $7.7 million for Q3 2025, down 72.4% from $27.91 million a year earlier and down 72.5% from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Long-Term Investments (2017 - 2025) Analysis & Trends
At the end of FY2024, Anaptysbio's Long-Term Investments was $35.47 million, up 31.2% from FY2023.
- Long-Term Investments carries a five-year compound annual growth rate of -8.2% (FY2019 to FY2024).
- Going back by year, Long-Term Investments was $27.03 million in FY2023 (-81.1%), $142.94 million in FY2022 (+113.0%), $67.1 million in FY2021 (+282.4%) and $17.55 million in FY2020 (-67.7%).
- The Q3 2025 figure represents the lowest quarterly Long-Term Investments since Q2 2021.
- Year-over-year, Long-Term Investments increased in two of the last eight quarters, with an average decline of 15.1%.
- The fastest year-over-year change in Long-Term Investments over five years came in Q3 2022 (growth of 867.8%), and the weakest in Q1 2021 (a decline of 85.9%).
- Business Quant data shows ANAB's Long-Term Investments at $28 million (Q2 2025), $43.02 million (Q1 2025) and $35.47 million (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Anaptysbio | 1.46 Bn | 346.34 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 7.70 Mn |
| Jun 30, 2025 | 28.00 Mn |
| Mar 31, 2025 | 43.02 Mn |
| Dec 31, 2024 | 35.47 Mn |
| Sep 30, 2024 | 27.91 Mn |
| Jun 30, 2024 | 42.65 Mn |
| Mar 31, 2024 | 15.47 Mn |
| Dec 31, 2023 | 27.03 Mn |
| Sep 30, 2023 | 40.20 Mn |
| Jun 30, 2023 | 59.24 Mn |
| Mar 31, 2023 | 94.93 Mn |
| Dec 31, 2022 | 142.94 Mn |
| Sep 30, 2022 | 147.51 Mn |
| Jun 30, 2022 | 129.99 Mn |
| Mar 31, 2022 | 91.20 Mn |
| Dec 31, 2021 | 67.10 Mn |
| Sep 30, 2021 | 15.24 Mn |
| Jun 30, 2021 | 5.48 Mn |
| Mar 31, 2021 | 7.06 Mn |
| Dec 31, 2020 | 17.55 Mn |
API Access
Anaptysbio Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();